Xiaochen Li
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pulmonary Hypertension Research and Treatments
Papers in
-
- Pulmonary Hypertension Research and Treatments 11
- Chronic Obstructive Pulmonary Disease (COPD) Research 8
- Renal cell carcinoma treatment 7
- Lung Cancer Treatments and Mutations 3
-
- COVID-19 Clinical Research Studies 8
- Co-authors
- Xiansheng Liu (27 shared papers)Min Xie (18 shared papers)Xiaopei Cao (9 shared papers)Jianping Zhao (5 shared papers)Muqing Yu (2 shared papers)Ke Wang (2 shared papers)Jing Cheng Shi (2 shared papers)Bo Wu (2 shared papers)
- Journals
- The Oncologist (3 papers)Respiratory Research (3 papers)International Journal of Oncology (2 papers)Journal of Cellular Physiology (2 papers)Respiratory Medicine (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiaochen Li
66 papers receiving 3.8k citations
Xiaochen Li's Hit Papers
Peers
Comparison fields: 5 of 129
- Infectious Diseases 1.5k
- Pulmonary and Respiratory Medicine 793
- Modeling and Simulation 106
- Nephrology 160
- General Dentistry 6
Countries citing papers authored by Xiaochen Li
This map shows the geographic impact of Xiaochen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Li more than expected).
Fields of papers citing papers by Xiaochen Li
This network shows the impact of papers produced by Xiaochen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Li. The network helps show where Xiaochen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaochen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Hit paper breakdown → | 2020 | 1688 |
| 2 | Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2020 | 257 |
| 3 | 2017 | 207 | |
| 4 | 2020 | 166 | |
| 5 | 2014 | 159 | |
| 6 | 2020 | 146 | |
| 7 | 2022 | 112 | |
| 8 | 2020 | 86 | |
| 9 | 2020 | 84 | |
| 10 | 2016 | 73 | |
| 11 | Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial Hit paper breakdown → | 2024 | 70 |
| 12 | 2020 | 59 | |
| 13 | 2015 | 54 | |
| 14 | 2014 | 51 | |
| 15 | 2020 | 49 | |
| 16 | 2015 | 41 | |
| 17 | The IRE1α-XBP1 pathway function in hypoxia-induced pulmonary vascular remodeling, is upregulated by quercetin, inhibits apoptosis and partially reverses the effect of quercetin in PASMCs. | 2019 | 41 |
| 18 | 2023 | 38 | |
| 19 | 2022 | 35 | |
| 20 | 2020 | 33 |
About Xiaochen Li
Xiaochen Li is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Cancer Research, Physiology and Surgery, having authored 71 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), COVID-19 Clinical Research Studies (8 papers), Renal cell carcinoma treatment (7 papers), Asthma and respiratory diseases (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Pulmonary and Respiratory Medicine (793 citations), Modeling and Simulation (106 citations), Nephrology (160 citations) and General Dentistry (6 citations). Xiaochen Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiansheng Liu, Min Xie, Xiaopei Cao, Jianping Zhao, Muqing Yu, Ke Wang, Jing Cheng Shi, Bo Wu, Junqing Yue and Ying Zhou. Their work appears in journals such as The Oncologist, Respiratory Research, International Journal of Oncology, Journal of Cellular Physiology and Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.